VivoSim Labs, Inc. Increase (Decrease) in Restricted Cash
VivoSim Labs, Inc. (VIVS) reported Increase (Decrease) in Restricted Cash of $88.00 thousand for the 71-month period ending 2013-03-31, per its 10-KT filed 2013-05-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2013-05-24
- VivoSim Labs, Inc. increase (decrease) in restricted cash for the quarter ending 2012-12-31 was -$321.00.
- VivoSim Labs, Inc. increase (decrease) in restricted cash for the quarter ending 2012-09-30 was $31.00.
- VivoSim Labs, Inc. increase (decrease) in restricted cash for the quarter ending 2012-06-30 was $50.29K.
- VivoSim Labs, Inc. increase (decrease) in restricted cash for the quarter ending 2012-03-31 was $38.00K.
- VivoSim Labs, Inc. increase (decrease) in restricted cash for fiscal 2012 was $88.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 3 month as first filed | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 59 month | Increase (Decrease) in Restricted Cash 62 month | Increase (Decrease) in Restricted Cash 65 month | Increase (Decrease) in Restricted Cash 68 month | Increase (Decrease) in Restricted Cash 71 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | $88.00K 10-KT · filed 2013-05-24 | |||||||||
| 2012-12-31 | -$321.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2013-05-24 | -$290.00 derived: sum of 2 quarters · filed 2013-05-24 | $50.00K derived: sum of 3 quarters · filed 2013-05-24 | $88.00K 10-KT · filed 2013-05-24 | $88.00K 10-K · filed 2013-03-15 | |||||
| 2012-09-30 | $31.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $50.32K derived: sum of 2 quarters · filed 2012-11-14 | $88.32K 10-Q · filed 2012-11-14 | $88.32K 10-Q · filed 2012-11-14 | ||||||
| 2012-06-30 | $50.29K derived: 10-Q 6 month − 10-KT 3 month · filed 2012-08-14 | $88.29K 10-Q · filed 2012-08-14 | $88.29K 10-Q · filed 2012-08-14 | |||||||
| 2012-03-31 | $38.00K 10-KT · filed 2013-05-24 | $38.29K 10-Q · filed 2012-05-15 | $38.29K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |